8RV8 image
Entry Detail
PDB ID:
8RV8
Keywords:
Title:
SARS-CoV-2 nsp16-nsp10 in complex with SAM derivative inhibitor 5
Biological Source:
PDB Version:
Deposition Date:
2024-01-31
Release Date:
2024-02-14
Method Details:
Experimental Method:
Resolution:
1.70 Å
R-Value Free:
0.19
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 31 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:2'-O-methyltransferase nsp16
Chain IDs:A
Chain Length:302
Number of Molecules:1
Biological Source:Severe acute respiratory syndrome coronavirus 2
Polymer Type:polypeptide(L)
Description:Non-structural protein 10
Chain IDs:B
Chain Length:142
Number of Molecules:1
Biological Source:Severe acute respiratory syndrome coronavirus 2
Primary Citation
Structural Basis for Inhibition of the SARS-CoV-2 nsp16 by Substrate-Based Dual Site Inhibitors.
Chemmedchem 19 e202400618 e202400618 (2024)
PMID: 39258386 DOI: 10.1002/cmdc.202400618

Abstact

Coronaviruses, including SARS-CoV-2, possess an mRNA 5' capping apparatus capable of mimicking the natural eukaryotic capping signature. Two SAM-dependent methylating enzymes play important roles in this process: nsp14 methylates the N7 of the guanosine cap, and nsp16-nsp10 methylates the 2'-O- of subsequent nucleotides of viral mRNA. The 2'-O-methylation performed by nsp16-nsp10 is crucial for the escape of the viral RNA from innate immunity. Inhibition of this enzymatic activity has been proposed as a way to combat coronaviruses. In this study, we employed X-ray crystallography to analyze the binding of the SAM analogues to the active site of nsp16-nsp10. We obtained eleven 3D crystal structures of the nsp16-nsp10 complexes with SAM-derived inhibitors, demonstrated different conformations of the methionine substituting part of the molecules, and confirmed that simultaneous dual-site targeting of both SAM and RNA sites correlates with higher inhibitory potential.

Legend

Protein

Chemical

Disease

Primary Citation of related structures